Wednesday, July 28, 2021

Simone Biles is a role model

Good morning. We have all the columns you're going to need today. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
usatoday.com

Today's Opinions
 
Wednesday, July 28
Mike Thompson, USA TODAY
Simone Biles is prioritizing her own mental health
Good morning. We have all the columns you're going to need today.

The news of Simone Biles announcing she was decided to withdraw from a Toyko Games competition to focus on her mental health was met with the usual mixed bag of reactions. But our columnist offers up that Biles is doing the correct thing for herself and her fans. 

Simone Biles is a role model

Simone Biles is helping young people realize that it's OK to take care of themselves. She's teaching them to prioritize their bodies because mental health and physical health are inextricably linked. 

Biles has been open about her depression after being sexually abused by team doctor Larry Nassar. She has overcome so much in her young life. Yet those now criticizing her actions exemplify the harsh reality of how stigmatizing issues of mental health are, particularly in the world of athletics.

Today's editorial cartoon 

Andy Marlette, USA TODAY Network
Andy Marlette, USA TODAY Network
USA TODAY Network
UpdatedEditorial cartoons on sports
July editorial cartoon gallery: Cartoons on Biden, COVID-19, politics

FDA sullies reputation in drug approval

In June, the FDA approved Aduhelm (generic name aducanumab), the first new treatment for Alzheimer's disease in two decades. As bioethicists who work in the areas of Alzheimer's disease and pharmaceutical policy, we can attest that this decision has generated more controversy than enthusiasm – and for good reasons. 

The drug has questionable benefits, substantial risks, a prescription label that remains overbroad and a hefty price tag.

The FDA's cozy interactions with pharmaceutical company Biogen, and its use of the accelerated approval pathway without consulting its committee of independent advisers, also raises concerns. 

Don't miss these

This new test for cancer could save your life. Here's why you can't get it.
Tokyo Olympics are not a bikini showcase. Let women athletes wear unitards, and hijabs
Few clues in case of girl sickened by foreign bacteria as others test positive
click here
 
FOLLOW US
FB TW IG

Problem viewing email? View in browser

Unsubscribe Manage Newsletters Terms of Service Privacy Policy/Your California Privacy Rights Privacy Notice Do Not Sell My Info/Cookie Policy Feedback

No comments:

Post a Comment

It’s a FULL Week of Savings!

The Best Deals Are Happening RIGHT NOW ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏...